GSK3 inhibitors regulate MYCN mRNA levels and reduce neuroblastoma cell viability through multiple mechanisms, including p53 and Wnt signaling (Q39053639)
Jump to navigation
Jump to search
scientific article published on 26 November 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | GSK3 inhibitors regulate MYCN mRNA levels and reduce neuroblastoma cell viability through multiple mechanisms, including p53 and Wnt signaling |
scientific article published on 26 November 2013 |
Statements
1 reference
GSK3 inhibitors regulate MYCN mRNA levels and reduce neuroblastoma cell viability through multiple mechanisms, including p53 and Wnt signaling (English)
1 reference
1 reference
1 reference
Aleksandar Krstic
1 reference
Thomas Schwarzl
1 reference
26 November 2013
1 reference
1 reference
Identifiers
1 reference